DE60024730D1 - Theanin enthaltende Zusammensetzung zur Unterdrückung von Verhaltensstörungen der Haustieren - Google Patents

Theanin enthaltende Zusammensetzung zur Unterdrückung von Verhaltensstörungen der Haustieren

Info

Publication number
DE60024730D1
DE60024730D1 DE60024730T DE60024730T DE60024730D1 DE 60024730 D1 DE60024730 D1 DE 60024730D1 DE 60024730 T DE60024730 T DE 60024730T DE 60024730 T DE60024730 T DE 60024730T DE 60024730 D1 DE60024730 D1 DE 60024730D1
Authority
DE
Germany
Prior art keywords
pets
theanin
suppression
containing composition
behavioral disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024730T
Other languages
English (en)
Other versions
DE60024730T2 (de
Inventor
Noriyuki Ishihara
Senji Sakanaka
Seiji Shu
Lekh Raj Juneja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Application granted granted Critical
Publication of DE60024730D1 publication Critical patent/DE60024730D1/de
Publication of DE60024730T2 publication Critical patent/DE60024730T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60024730T 1999-07-19 2000-07-19 Theanin enthaltende Zusammensetzung zur Unterdrückung von Verhaltensstörungen der Haustieren Expired - Lifetime DE60024730T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20430799A JP4669095B2 (ja) 1999-07-19 1999-07-19 ペットの問題行動抑制組成物
JP20430799 1999-07-19

Publications (2)

Publication Number Publication Date
DE60024730D1 true DE60024730D1 (de) 2006-01-19
DE60024730T2 DE60024730T2 (de) 2006-08-03

Family

ID=16488326

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024730T Expired - Lifetime DE60024730T2 (de) 1999-07-19 2000-07-19 Theanin enthaltende Zusammensetzung zur Unterdrückung von Verhaltensstörungen der Haustieren

Country Status (7)

Country Link
US (1) US6297280B1 (de)
EP (1) EP1074252B1 (de)
JP (1) JP4669095B2 (de)
AT (1) ATE312603T1 (de)
CA (1) CA2313878C (de)
DE (1) DE60024730T2 (de)
ES (1) ES2254078T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035190C5 (de) 2000-07-20 2009-07-16 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren und Vorrichtung zur Fluoreszenzmessung
JP3907964B2 (ja) * 2001-04-25 2007-04-18 株式会社 伊藤園 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物
JP4812968B2 (ja) * 2001-06-06 2011-11-09 太陽化学株式会社 注意欠陥多動性障害改善用組成物
HUP0401154A2 (hu) * 2001-07-20 2004-10-28 Pfizer Products Inc. NK-1 receptor antagonisták használata kutyák, macskák és lovak nemkívánatos viselkedésének módosítására
US20030194478A1 (en) † 2002-04-12 2003-10-16 Davenport Gary Mitchell Dietary methods for canine performance enhancement
JP2005532078A (ja) * 2002-07-12 2005-10-27 ザ・アイムス・カンパニー イヌの行動における食餌及び人間との交流の相乗効果
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8921422B2 (en) 2003-10-01 2014-12-30 The Iams Company Methods and kits for enhancing ability to learn in a puppy or kitten
JP2008169144A (ja) * 2007-01-11 2008-07-24 Ito En Ltd 心的外傷後ストレス障害予防剤、治療剤及び飲食物
US20080299286A1 (en) * 2007-06-04 2008-12-04 David B Josephson Palatability enhancing compositions and foods for pets, and methods regarding the same
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
JP5979816B2 (ja) 2008-01-04 2016-08-31 ネステク ソシエテ アノニム 不飽和脂肪酸及び酸化窒素放出化合物を含む組成物、並びに認知機能及び関連の機能を高めるためのそれらの使用
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
DE102015009525A1 (de) 2015-07-17 2017-01-19 Ulrich Jüstrich Holding AG Neuartige Zusammensetzungen zur Anwendung bei prämenopausalen und menopausalen Frauen zur Bereitstellung verbesserter Nahrungsergänzung und/oder Linderung der Menopausesymptome
CA3208235A1 (en) 2015-08-31 2017-03-09 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein
JP2022012658A (ja) * 2020-07-02 2022-01-17 太陽化学株式会社 ペットのアレルギー緩和用経口組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54129130A (en) * 1978-03-27 1979-10-06 Mitsubishi Chem Ind Ltd Method for promoting roughage digestion of animal
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
ES2036910B1 (es) * 1990-10-11 1994-01-16 Quimica Mobi S A Aditivo corrector para piensos a base de cloruro de colina.
JPH06237734A (ja) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
JPH05229938A (ja) * 1991-12-25 1993-09-07 Food Design Gijutsu Kenkyu Kumiai 血圧降下剤
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
JPH0873350A (ja) * 1994-09-06 1996-03-19 Itouen:Kk 脳機能改善剤、食品及び飲料
JPH08245378A (ja) * 1995-03-09 1996-09-24 Sagami Chem Res Center 精神安定剤
JP4627813B2 (ja) * 1995-06-27 2011-02-09 太陽化学株式会社 テアニン含有組成物
JPH10165109A (ja) * 1996-12-06 1998-06-23 Taiyo Kagaku Co Ltd 飼料組成物及び飼料
JP3731983B2 (ja) * 1997-08-27 2006-01-05 明治製菓株式会社 痴呆犬の夜鳴き改善薬
CA2320368C (en) * 1998-02-23 2007-08-21 Taiyo Kagaku Co., Ltd. Composition comprising theanine
CN1156545C (zh) * 2002-04-30 2004-07-07 姚惠渥 无毒无污染聚苯乙烯涂料及其制备方法

Also Published As

Publication number Publication date
ES2254078T3 (es) 2006-06-16
CA2313878C (en) 2008-12-02
EP1074252B1 (de) 2005-12-14
CA2313878A1 (en) 2001-01-19
DE60024730T2 (de) 2006-08-03
EP1074252A3 (de) 2002-01-16
US6297280B1 (en) 2001-10-02
JP2001031566A (ja) 2001-02-06
ATE312603T1 (de) 2005-12-15
EP1074252A2 (de) 2001-02-07
JP4669095B2 (ja) 2011-04-13

Similar Documents

Publication Publication Date Title
DE60024730D1 (de) Theanin enthaltende Zusammensetzung zur Unterdrückung von Verhaltensstörungen der Haustieren
NZ301681A (en) composition containing an emulsion comprising fatty acid derivatives and a compound of vegetal origin which can be used to modify the behaviour of cats
DE602004018680D1 (de) Verfahren zur verringerung des exkrementgeruchs von heimtieren
FR2753447B1 (fr) Hydroxyphenyltriazines comme agents stabilisants de matieres organiques
CY1107438T1 (el) Παραγωγα καρβοξυλικου οξεος, τα οποια παρεμποδιζουν την συνδεσιν ιντεγκρινων εις τους υποδοχεις των
ATE308880T1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
NZ334186A (en) Neurotrophic heterocyclic esters and amides with an affinity to FKBP-type immunophilins
DK1273299T3 (da) Minoxidilinindeholdende praparater
DE60019586D1 (de) Myostatin genpromoter und inhibierung dessen aktivierung
DE60026844D1 (de) Verfahren zur herstellung von 3,3-dimethylbutanal
DE69815549D1 (de) Pestizide zusammensetzung
DE69512589T2 (de) Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
BR9810567A (pt) Composições antimicrobianas sinérgicas contendo uma dimetilamida de um ácido carboxìlico com uma mistura de 2-(tiocianometiltio) benzotiazol e um metileno-bis (tiocianato) e uso destes
DE69420961T2 (de) Zusammensetzungen zur duftfreisetzung die geringe mengen von fluechtigen organischen komponenten enthalten
PT999750E (pt) Composicao antifungica
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ES2122763T3 (es) Composiciones antimicrobianas y utilizacion de las mismas.
BR0107544A (pt) Composição de promoção de secreção de bile
EP1342410A3 (de) Transgenes Tier mit Mangel in einem funktionellem Galanin Gens
ATE306263T1 (de) Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
DE69700900D1 (de) Kautschukzusammensetzungen, die Arylbiscitraconsäuremonoamide enthalten
DE69827163D1 (de) Phytase zur vorbeugung oder behandlung von mastitis
ATE349544T1 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln
WO2002066666A3 (de) Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition